{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T01:37:38Z","timestamp":1710985058759},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.remnie.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T19:27:43Z","timestamp":1707247663000},"page":"100-106","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between pre-radical prostatectomy standardized SUVmax ratios detected on 68Ga-PSMA-I&T PET\/CT and final histopathology outcomes: an in-depth analysis"],"prefix":"10.1016","volume":"43","author":[{"given":"M.G.","family":"Ar\u0131kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Soyluo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dc.","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ta\u015ftekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Elbo\u011fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Arda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.remnie.2024.02.002_bib0005","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer."},{"issue":"6","key":"10.1016\/j.remnie.2024.02.002_bib0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.urology.2007.02.054","article-title":"Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer","volume":"69","author":"Loeb","year":"2007","journal-title":"Urology."},{"issue":"5 Pt 2","key":"10.1016\/j.remnie.2024.02.002_bib0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0022-5347(17)32397-2","article-title":"5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer","volume":"152","author":"Catalona","year":"1994","journal-title":"J Urol."},{"issue":"4","key":"10.1016\/j.remnie.2024.02.002_bib0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s13139-017-0476-7","article-title":"(68)Ga-PSMA PET\/CT imaging predicting intraprostatic tumor extent, extracapsular extension and seminal vesicle invasion prior to radical prostatectomy in patients with prostate cancer","volume":"51","author":"von Klot","year":"2017","journal-title":"Nucl Med Mol Imaging."},{"issue":"3","key":"10.1016\/j.remnie.2024.02.002_bib0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol."},{"issue":"6","key":"10.1016\/j.remnie.2024.02.002_bib0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology."},{"issue":"1","key":"10.1016\/j.remnie.2024.02.002_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0360-3016(94)90138-4","article-title":"Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer","volume":"28","author":"Roach","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.remnie.2024.02.002_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis","volume":"70","author":"de Rooij","year":"2016","journal-title":"Eur Urol."},{"issue":"3","key":"10.1016\/j.remnie.2024.02.002_bib0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS Version 2 lexicon: a multicenter study of six experienced prostate radiologists","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology."},{"issue":"4","key":"10.1016\/j.remnie.2024.02.002_bib0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"2","key":"10.1016\/j.remnie.2024.02.002_bib0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.remnie.2024.02.002_bib0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","article-title":"(68)Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"3","key":"10.1016\/j.remnie.2024.02.002_bib0065","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41391-021-00347-y","article-title":"Preoperative 68Ga-PSMA-I&T PET\/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection","volume":"24","author":"Dekalo","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"10.1016\/j.remnie.2024.02.002_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bju.15134","article-title":"Histological comparison between predictive value of preoperative 3-T multiparametric MRI and (68) Ga-PSMA PET\/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer","volume":"127","author":"Franklin","year":"2021","journal-title":"BJU Int."},{"issue":"7","key":"10.1016\/j.remnie.2024.02.002_bib0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2967\/jnumed.118.223099","article-title":"Rapid modulation of PSMA expression by androgen deprivation: serial (68)Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade","volume":"60","author":"Emmett","year":"2019","journal-title":"J Nucl Med."},{"issue":"2","key":"10.1016\/j.remnie.2024.02.002_bib0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2967\/jnumed.117.195172","article-title":"Immunohistochemical validation of PSMA expression measured by (68)Ga-PSMA PET\/CT in primary prostate cancer","volume":"59","author":"Woythal","year":"2018","journal-title":"J Nucl Med."},{"issue":"2","key":"10.1016\/j.remnie.2024.02.002_bib0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"AJR Am J Roentgenol."},{"issue":"1","key":"10.1016\/j.remnie.2024.02.002_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-020-00651-z","article-title":"Tumour-to-liver ratio determined by [(68)Ga]Ga-DOTA-TOC PET\/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours","volume":"10","author":"Kim","year":"2020","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.remnie.2024.02.002_bib0095","article-title":"The PET-derived tumor-to-liver standard uptake ratio (SUVTLR) is superior to tumor SUVmax in predicting tumor response and survival after chemoradiotherapy in patients with locally advanced esophageal cancer","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.remnie.2024.02.002_bib0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13550-019-0572-z","article-title":"Evaluation of SUV normalized by lean body mass (SUL) in (68)Ga-PSMA11 PET\/CT: a bi-centric analysis","volume":"9","author":"Gafita","year":"2019","journal-title":"EJNMMI Res."},{"issue":"4","key":"10.1016\/j.remnie.2024.02.002_bib0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.115.169243","article-title":"Correlation of intraprostatic tumor extent with (6)(8)Ga-PSMA distribution in patients with prostate cancer","volume":"57","author":"Rahbar","year":"2016","journal-title":"J Nucl Med."},{"issue":"11","key":"10.1016\/j.remnie.2024.02.002_bib0110","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s00259-018-4037-9","article-title":"(68)Ga-PSMA-617 PET\/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients","volume":"45","author":"Liu","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"9","key":"10.1016\/j.remnie.2024.02.002_bib0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/pros.23812","article-title":"Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer","volume":"79","author":"Yilmaz","year":"2019","journal-title":"Prostate."},{"issue":"11","key":"10.1016\/j.remnie.2024.02.002_bib0120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","article-title":"Normal distribution pattern and physiological variants of 68Ga-PSMA-I&T-11 PET\/CT imaging","volume":"37","author":"Demirci","year":"2016","journal-title":"Nucl Med Commun."},{"issue":"1","key":"10.1016\/j.remnie.2024.02.002_bib0125","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res."},{"issue":"11","key":"10.1016\/j.remnie.2024.02.002_bib0130","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2967\/jnumed.116.172627","article-title":"68Ga-PSMA-I&T PET\/CT detects the location and extent of primary prostate cancer","volume":"57","author":"Fendler","year":"2016","journal-title":"J Nucl Med."},{"issue":"5","key":"10.1016\/j.remnie.2024.02.002_bib0135","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2009.07.020","article-title":"Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy","volume":"182","author":"Kordan","year":"2009","journal-title":"J Urol."},{"issue":"1","key":"10.1016\/j.remnie.2024.02.002_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7150\/thno.16638","article-title":"Comparison of (68)Ga-HBED-CC PSMA-PET\/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology","volume":"7","author":"Zamboglou","year":"2017","journal-title":"Theranostics."},{"issue":"5","key":"10.1016\/j.remnie.2024.02.002_bib0145","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00259-015-3257-5","article-title":"MRI versus (6)(8)Ga-PSMA PET\/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer","volume":"43","author":"Zamboglou","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"11","key":"10.1016\/j.remnie.2024.02.002_bib0150","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1007\/s00259-017-3752-y","article-title":"The accuracy of (68)Ga-PSMA PET\/CT in primary lymph node staging in high-risk prostate cancer","volume":"44","author":"Obek","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"2","key":"10.1016\/j.remnie.2024.02.002_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-5347(01)65201-7","article-title":"Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications","volume":"157","author":"Cookson","year":"1997","journal-title":"J Urol."},{"issue":"8 Pt 2","key":"10.1016\/j.remnie.2024.02.002_bib0160","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1111\/j.1464-410X.2011.10119.x","article-title":"Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence","volume":"108","author":"Corcoran","year":"2011","journal-title":"BJU Int."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808924000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808924000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:03:03Z","timestamp":1710979383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808924000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2253808924000089"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2024.02.002","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between pre-radical prostatectomy standardized SUVmax ratios detected on 68Ga-PSMA-I&T PET\/CT and final histopathology outcomes: an in-depth analysis","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2024.01.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}